Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01473368 · ClinicalTrials.gov registry record · NA
Effects of S. Boulardii and Amoxicillin/Clavulanate on Gut Microbiota
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 53
- Enrollment target
NCT01473368 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 53 participants.
The verdict
NCT01473368, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
Study Summary
The purpose of this study is to compare and contrast the effects of the probiotic Saccharomyces boulardii, the antibiotic amoxicillin/clavulanate and the combination on the gut microbiota of healthy volunteers.
Interventions
- DIETARY_SUPPLEMENT Saccharomyces boulardii
- DRUG Amoxicillin Clavulanate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2012-04 |
| Est. Completion | 2013-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01473368
The ClinicalTrials.gov registry entry for NCT01473368 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Saccharomyces boulardii is the first listed.
NCT01473368 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01473368 about?
NCT01473368 is a clinical study titled "Effects of S. Boulardii and Amoxicillin/Clavulanate on Gut Microbiota". The purpose of this study is to compare and contrast the effects of the probiotic Saccharomyces boulardii, the antibiotic amoxicillin/clavulanate and the combination on the gut microbiota of healthy volunteers.
What is the current status of trial NCT01473368?
This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2012-04. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01473368?
The interventions under investigation include: Saccharomyces boulardii (DIETARY_SUPPLEMENT), Amoxicillin Clavulanate (DRUG).
Who is sponsoring clinical trial NCT01473368?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.